John Carroll from fiercebiotech.com just published an intriguing article on recent efforts by parents of children with severe illnesses including Duchene Muscular Dystrophy (DMD) in the wake of a recent FDA denial for compassionate use. Public relations efforts including flash mob demonstrations and petitions to FDA for pilot studies have been used. As John Carroll shares, “There are no easy answers here. Just hard questions.” To read the complete article click here.
Obstacles Facing Biosimilars
Still in its infancy in the U.S., the industry faces some growing pains.
Life Science Accelerated
Our experts are dedicated to expediting life science product development regulatory pathways.